Dmitry Balyasny’s Varian Medical Systems, Inc. VAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-473,233
Closed -$83.5M 2641
2021
Q1
$83.5M Sell
473,233
-205,719
-30% -$36.2M 0.41% 37
2020
Q4
$119M Buy
678,952
+322,135
+90% +$55.9M 0.66% 16
2020
Q3
$61.4M Buy
+356,817
New +$56.1M 0.45% 33
2020
Q1
Sell
-80,912
Closed -$11.5M 1652
2019
Q4
$11.5M Buy
+80,912
New +$10.3M 0.07% 388
2019
Q2
Sell
-141,375
Closed -$20M 1824
2019
Q1
$20M Sell
141,375
-123,258
-47% -$16.2M 0.13% 221
2018
Q4
$30M Buy
264,633
+246,205
+1,336% +$28.2M 0.22% 125
2018
Q3
$2.06M Sell
18,428
-23,757
-56% -$2.69M 0.01% 967
2018
Q2
$4.8M Buy
42,185
+35,295
+512% +$4.22M 0.02% 675
2018
Q1
$845K Buy
6,890
+591
+9% +$70.5K ﹤0.01% 1282
2017
Q4
$700K Sell
6,299
-213,155
-97% -$22.9M ﹤0.01% 1444
2017
Q3
$22M Sell
219,454
-108,072
-33% -$11.1M 0.09% 302
2017
Q2
$33.8M Buy
327,526
+187,814
+134% +$18.1M 0.14% 202
2017
Q1
$12.7M Buy
139,712
+126,484
+956% +$10.5M 0.06% 410
2016
Q4
$1.04M Buy
+13,228
New +$1.07M 0.01% 1014

Other funds holding VAR

Dmitry Balyasny's VAR Position: Q2 2021 in Review

Dmitry Balyasny sold out of Varian Medical Systems, Inc. (VAR) in Q2 2021, closing a stake of 473,233 shares — an estimated $83.5M sold.

Dmitry Balyasny first reported a position in VAR in Q4 2016 and held it in 14 quarters. The position peaked at $119M in Q4 2020. 1 fund tracked by Wall St. Rank holds VAR as of Q2 2021.

  • Dmitry Balyasny reported no remaining Varian Medical Systems, Inc. position as of Q2 2021 after selling out during the quarter.
  • Dmitry Balyasny sold 473,233 Varian Medical Systems, Inc. shares in Q2 2021, an estimated $83.5M.
  • Dmitry Balyasny first reported a position in Varian Medical Systems, Inc. in Q4 2016 and held it in 14 quarters.
  • Dmitry Balyasny's Varian Medical Systems, Inc. position peaked at $119M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q2 2021.

Based on Balyasny Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.